Peg-asparaginase & other oncology products
Product Description
Invex Health
-
IN
-
2022On CPHI since
-
4Certificates
-
25 - 49Employees
Company types
Primary activities
Categories
Specifications
Invex Health
-
IN
-
2022On CPHI since
-
4Certificates
-
25 - 49Employees
Company types
Primary activities
More Products from Invex Health (6)
-
Product Biosimilars
Products: Trastuzumab Bevacizumab Rituximab Adalimumab Etanercept Tenecteplase Plant Approval: EUGMP, WHO GMP, Philippines FDA & TMMDA -
Product Blood Products
Products: Human Albumin IVIG Dried Factor VIII Fraction Erythropoietin Darbepoetin alfa Injection Filgrastim Human Anti-D Immunoglobulin Plant Approval: WHOGMP, Kenya, Ethiopia -
Product Tinefcon
A patented & clinically proven product for management of psoriasis, backed up with years of extensive R&D and clinical trials1. Tinefcon is the WORLD’s first ORAL TNF- Alpha down regulator
2. Tinefcon presents the only holistic approach for the&nb... -
Product Bevacizumab & other Biosimilars
• Trastuzumab • Rituximab • Adalimumab • Etanercept • Tenecteplase & More -
Product Human albumin & other Blood products
• Human Albumin IVIG • Dried Factor VIII Fraction • Erythropoietin • Darbepoetin alfa Injection • Filgrastim • Human Anti-D Immunoglobulin -
Product Cardio-Diabetics
• Rifaximin tablets • Rivaroxaban tablets • Apixaban tablets and more.
Invex Health resources (1)
-
Brochure Product list (ROW market)
These are the products available for ROW markets with dossier status.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance